United Therapeutics | UTHR - Ordinary Share Capital



United Therapeutics reported $45.22M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Amarin USD 308.15M 2.85M Mar/2025
Ardelyx USD 240.77M 240.74M Jun/2025
Baxter International USD 683M 0 Dec/2024
Bayer EUR 982.42M 1.53B Jun/2025
Biogen USD 146.6M 146.5M Jun/2025
BioMarin Pharmaceutical USD 192M 191.81M Jun/2025
Gilead Sciences USD 1.24B 3M Jun/2025
GlaxoSmithKline GBP 4.15B 2.8B Jun/2025
Halozyme Therapeutics USD 117.62M 117.5M Jun/2025
Insmed USD 211.11M 209.29M Jun/2025
Ionis Pharmaceuticals USD 159.2M 159.04M Jun/2025
J&J USD 3.12B 0 Mar/2025
Moderna USD 389M 388.96M Jun/2025
Pfizer USD 5.68B 5.2B Jun/2025
PTC Therapeutics USD 79.38M 79.3M Jun/2025
Regeneron Pharmaceuticals USD 106.4M 106.4M Jun/2025
Sarepta Therapeutics USD 97.71M 97.7M Jun/2025
Teva Pharmaceutical Industries USD 1.15B 1.09B Jun/2025
United Therapeutics USD 45.22M 44.42M Jun/2025
Vertex Pharmaceuticals USD 256.3M 253.7M Jun/2025